alexa Contact Editorial in Chief: Neurology and Neurophysiology Journals
ISSN: 2155-9562

Journal of Neurology & Neurophysiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..
Paul A Lapchak Editor-in-Chief
Paul A Lapchak
Cedars-Sinai Medical Center
Read Interview session with Paul A Lapchak

Dr. Paul A. Lapchak has received his PhD in Pharmacology in 1988 from McGill University (Montreal, Quebec). Currently, he is the Director of Translational Research at Cedars-Sinai Medical Center in Los Angeles, CA. Prior to joining Cedars-Sinai Medical Center, while at the University of California, Dr. Lapchak advanced 2 embolic stroke models to develop new stroke treatments. He is currently serving as an editorial member of Translational Stroke Research and is an active reviewer for STROKE, Experimental Neurology, Brain Research, amongst others. He has authored over 100 peer-reviewed research articles, over 40 review articles and is currently co-editing a new book entitled Translational Stroke Research: From target selection to clinical trials. He is a member of American Heart Association and the Society For Neuroscience. He has been honored as a Fellow of the American Heart Organization (FAHA) for his dedication to the translational development of novel methods to treat acute ischemic stroke and hemorrhagic stroke and has also received a Chemical Industry Award honor.

Research Interest

Dr. Lapchak currently directs a translational stroke research laboratory funded by a translational research grant from NINDS. Dr. Lapchak is focused on developing natural product analogs to treat ischemic stroke. Natural products derived from plants and other natural sources are an untapped resource of bioactive compounds. The emphasis is on polyphenolic compounds such as curcumin and high affinity curcumin-derivatives with novel mechanisms of action and low toxicity profiles. Moreover, his laboratory is actively engaged in studies to further the development of transcranial laser therapy to promote recovery of function following a stroke by elucidating the mechanism of action of light therapy. His laboratory is also working to develop new methods to attenuate thrombolytic-induced intracerebral hemorrhage and provide neuroprotection to hemorrhage patients.

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version